9AINH - Overview: Factor IX Inhibitor Profile, Professional Interpretation
Interpretation for the detection and titering of coagulation inhibitor to the specific factor requested, primarily factor IX in patients with hemophilia B
7AINH - Overview: Factor VII Inhibitor Profile, Professional Interpretation
Interpretation of testing for the detection and quantitation of inhibitor to factor VII
FPHET - Overview: Anti-Phosphatidylethanolamine Panel
Anti-Phosphatidylethanolamine Panel
Interpretation of testing performed as part of a profile to evaluate laboratory evidence of disseminated intravascular coagulation
7INHT - Overview: Factor VII Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor VII testing
5INHT - Overview: Factor V Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor V testing
5AINH - Overview: Factor V Inhibitor Profile, Professional Interpretation
Interpretation of testing for factor V inhibitors
10INT - Overview: Factor X Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor X testing
FKEMS - Overview: Ketamine and Metabolite Screen, Plasma
Ketamine and Metabolite Screen, Plasma
9INHT - Overview: Factor IX Inhibitor Profile Technical Interpretation
Technical interpretation of inhibitor to factor IX testing for patients with hemophilia B
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....